pyrrolidonecarboxylic acid has been researched along with ranitidine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| LePard, KJ; Mohammed, JR; Stephens, RL | 1 |
| Fatuzzo, P; Granata, A; Portale, G; Scollo, V; Zanoli, L | 1 |
2 other study(ies) available for pyrrolidonecarboxylic acid and ranitidine
| Article | Year |
|---|---|
Gastric ECL-cell hyperplasia produces enhanced basal and stimulated gastric acid output but not gastric erosion formation in the rat.
Topics: Animals; Carbachol; Enterochromaffin Cells; Female; Gastric Acid; Gastric Mucosa; Histamine; Hyperplasia; Indomethacin; Pentagastrin; Pyrrolidonecarboxylic Acid; Ranitidine; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Stress, Physiological; Thyrotropin-Releasing Hormone | 1997 |
Proton pump inhibitors and symptomatic hypomagnesemic hypoparathyroidism.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Biomarkers; Cerebellar Diseases; Dietary Supplements; Drug Substitution; Humans; Hypocalcemia; Hypokalemia; Hypoparathyroidism; Magnesium; Male; Pantoprazole; Proton Pump Inhibitors; Pyrrolidonecarboxylic Acid; Ranitidine; Seizures; Treatment Outcome | 2017 |